FDA Investigator Perry T Nichols

Perry T Nichols has conducted inspections on 29 sites in 1 countries as of 25 Jul 2003. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
29
Last Inspection Date:
25 Jul 2003
Investigator Role:
FDA Investigator
Redica ID:
100003352
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Perry T Nichols:
Alice S Tsao, Amber D Brodas, Amy Wyan Mai, Anissa M Vargas, Ann B Okon, Ann M Stewart, Anna M Alexander, Antonina Aydanian, Aziz A Mamur, Benton M Ketron, Brian R Yaun, Bruce G Cooper, Catherine M Beer, Charisse K Green, Charles Jewell, Dana A Razzano, Dave M Deroche, David R Delucia, Demitria J Argiropoulos, Demitria J Xiradakis, Denise L Terzian, Dennis E Guilfoyle, PhD, Diane L Raccasi, Donald G Gordon, Donald J Ullstrom, Evan Tong, Felix Maldonado, Frank Verni, Freyja V Lynn, Gregson A Joseph, Guerlain Ulysse, Helen B Ricalde, Iram R Hassan, PhD, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, Janet A Rajan, Jennifer L Bridgewater, Jose Acruz Gonzalez, Joseph Milcetic, Joy P Matthias, Judy Keihl, Juliana Falla, Julie D Bringger, Julie Scoma, Karen L Kosar, Kellie Leveille, Kenneth H Williams, Kevin A Gonzalez, Kristina L Conroy, L Gnnmassimia Massimilla, PharmD, Lata C Mathew, PhD, Lawrence W Farina, LCDR Chad N Thompson, Leena Thomas, Lisa Mathew, Lori Peters, Margaret E Sarles, Maria Joselopez Barragan, PhD, Marjorie A Shapiro, PhD, Marsha W Major, Martha T Olone, Mary Davis Lopez, Mary M Finn, Mate Tolnay, Matthew A Spataro, Melissa A Henaghan, Michael A Charles, Michael G Sinkevich, Michael Levin, Michael R Dominick, Mihaly S Ligmond, Milan S Blake, Mindy M Chou, Nancy T Waites, Omotunde O Osunsanmi, Paul E Stein, Paul Mouris, Paula A Trost, Peter R Caparelli, Philip F Istafanos, DMV, MS, Prabhu P Raju, Richard W Thornton, Robert C Steyert, Robert J Veitch, Robert Jennings, Rochelle K Kimmel, Samuel T Walker, Sandra D Thompson, Sarah B Tanksley, Scott E Norris, Shari L Kahn, Simone E Pitts, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stella Yuen, Steven C Nattrass, Susan F Laska, MS, Susan M Jackson, Syeda N Mahazabin, Tara K Carmody, Tej Poonai, Thomas P Hansen, Tina S Roecklein, Uduak M Inokon, Unnee Ranjan, Valentino Fiorella, Vanessa M Williams, Wanda Eng, Wayne E Seifert, Wayne J Meyer, William M Rennells, Winston R Alejo, Xiaoping Guan, Yvins Dezan, Yvonne M Santiago

Perry T Nichols's Documents

Publish Date Document Type Title
January, 2002 EIR Strides Pharma, Inc - EIR, 2002-01-24
June, 2000 FDA 483 Response Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483R, 2000-06-30
February, 2001 EIR Axiom Pharmaceutical Corporation - EIR, 2001-02-08
June, 2001 EIR Barr Laboratories Inc. - EIR, 2001-06-29
January, 2000 FDA 483 Emisphere Technologies, Inc. - Form 483, 2000-01-21
August, 2001 FDA 483 Response Axiom Pharmaceutical Corporation - Form 483R, 2001-08-14
August, 2001 EIR Axiom Pharmaceutical Corporation - EIR, 2001-08-03
November, 2000 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2000-11-16
March, 2000 FDA 483 Strides Pharma, Inc - Form 483, 2000-03-23
January, 2000 FDA 483 Response Emisphere Technologies, Inc. - Form 483R, 2000-02-07
March, 2000 FDA 483 Response Strides Pharma, Inc - Form 483R, 2000-04-07
October, 2000 EIR Epic Pharma, LLC - EIR, 2000-10-03
August, 2001 FDA 483 Axiom Pharmaceutical Corporation - Form 483, 2001-08-03
February, 2001 EIR Barr Laboratories Inc. - EIR, 2001-02-27
March, 2000 EIR Strides Pharma, Inc - EIR, 2000-03-23
June, 2000 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2000-06-23

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more